Justina C. Wu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha-Galactosidase | 1 | 2010 | 56 | 0.360 |
Why?
|
| Fabry Disease | 1 | 2010 | 89 | 0.340 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2010 | 858 | 0.320 |
Why?
|
| Transforming Growth Factor alpha | 3 | 1994 | 135 | 0.270 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 1225 | 0.140 |
Why?
|
| Echocardiography | 5 | 2017 | 5096 | 0.130 |
Why?
|
| Cardiology Service, Hospital | 1 | 2017 | 246 | 0.130 |
Why?
|
| Liver | 5 | 1995 | 7479 | 0.110 |
Why?
|
| Niacinamide | 1 | 1994 | 416 | 0.110 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2012 | 1421 | 0.100 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2012 | 143 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2003 | 915 | 0.090 |
Why?
|
| European Union | 1 | 2009 | 158 | 0.080 |
Why?
|
| Peptic Ulcer | 1 | 2009 | 223 | 0.080 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 223 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2265 | 0.070 |
Why?
|
| Helicobacter pylori | 1 | 2009 | 384 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2012 | 1537 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1994 | 2217 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 1994 | 13028 | 0.060 |
Why?
|
| Vasodilation | 2 | 2003 | 944 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 11708 | 0.050 |
Why?
|
| Endotoxemia | 1 | 2003 | 207 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2009 | 1131 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1874 | 0.050 |
Why?
|
| Systole | 1 | 2003 | 958 | 0.050 |
Why?
|
| Cell Division | 5 | 1995 | 4568 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2009 | 1491 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1995 | 2942 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2002 | 9731 | 0.040 |
Why?
|
| Cause of Death | 1 | 2009 | 3580 | 0.040 |
Why?
|
| Transgenes | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2003 | 996 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2010 | 1620 | 0.040 |
Why?
|
| Mice, Nude | 2 | 1994 | 3680 | 0.040 |
Why?
|
| Ploidies | 2 | 1994 | 281 | 0.040 |
Why?
|
| Hypotension | 1 | 2003 | 884 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2017 | 53250 | 0.040 |
Why?
|
| Ventricular Function, Left | 2 | 2012 | 3660 | 0.030 |
Why?
|
| Stroke Volume | 2 | 2012 | 5002 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 1994 | 158 | 0.030 |
Why?
|
| Body Weight | 2 | 2003 | 4670 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 1994 | 223 | 0.030 |
Why?
|
| Codon | 1 | 1995 | 611 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1994 | 134 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1586 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1994 | 272 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1995 | 755 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 424 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 2074 | 0.030 |
Why?
|
| Mice | 8 | 2003 | 81154 | 0.030 |
Why?
|
| Male | 12 | 2017 | 349776 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3794 | 0.030 |
Why?
|
| Heart Rate | 1 | 2003 | 4091 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39001 | 0.030 |
Why?
|
| Connexins | 1 | 1994 | 357 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2003 | 534 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1994 | 709 | 0.030 |
Why?
|
| Cell Line | 3 | 1995 | 15993 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15142 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 21824 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2003 | 3817 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2003 | 689 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2003 | 1862 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12243 | 0.020 |
Why?
|
| Sex Factors | 1 | 2003 | 10394 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4552 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1994 | 1728 | 0.020 |
Why?
|
| Animals | 10 | 2003 | 168660 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1994 | 1125 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2010 | 292 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 10896 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 18027 | 0.020 |
Why?
|
| DNA Replication | 1 | 1994 | 1399 | 0.020 |
Why?
|
| Female | 7 | 2017 | 380020 | 0.020 |
Why?
|
| Transfection | 1 | 1995 | 5892 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 768 | 0.020 |
Why?
|
| Heart | 1 | 2000 | 4460 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 970 | 0.020 |
Why?
|
| Young Adult | 2 | 2010 | 56392 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4974 | 0.020 |
Why?
|
| Middle Aged | 5 | 2012 | 213241 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2009 | 388 | 0.020 |
Why?
|
| Aorta | 2 | 2003 | 2062 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2009 | 844 | 0.020 |
Why?
|
| Adolescent | 2 | 2010 | 85729 | 0.020 |
Why?
|
| Organ Size | 2 | 2003 | 2241 | 0.020 |
Why?
|
| Exercise Test | 1 | 2012 | 2074 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 2298 | 0.010 |
Why?
|
| Probability | 1 | 2009 | 2505 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1991 | 1743 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1991 | 2006 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2883 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6356 | 0.010 |
Why?
|
| Nitrites | 1 | 2003 | 160 | 0.010 |
Why?
|
| Age Distribution | 1 | 2009 | 2899 | 0.010 |
Why?
|
| Aged | 3 | 2010 | 163178 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2009 | 868 | 0.010 |
Why?
|
| Incidence | 2 | 2012 | 20948 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 205 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 894 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40038 | 0.010 |
Why?
|
| Phenotype | 2 | 2002 | 16361 | 0.010 |
Why?
|
| Liver Regeneration | 2 | 1994 | 211 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2002 | 5179 | 0.010 |
Why?
|
| Adult | 3 | 2010 | 213889 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 494 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 739 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2003 | 597 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 414 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2002 | 569 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 430 | 0.010 |
Why?
|
| Humans | 8 | 2017 | 743811 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1800 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2012 | 5986 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 697 | 0.010 |
Why?
|
| Proteins | 1 | 1994 | 6098 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2050 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6539 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9848 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 8337 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1284 | 0.010 |
Why?
|
| Fibrosis | 1 | 2003 | 2030 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2010 | 6441 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 1705 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1994 | 11478 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10251 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3701 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2002 | 11360 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 1027 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2003 | 1631 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 192 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 12354 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 57744 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1581 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 2504 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 15211 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1991 | 12066 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 21733 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15526 | 0.010 |
Why?
|
| Mutation | 1 | 1995 | 29777 | 0.010 |
Why?
|
| Quality of Life | 1 | 2012 | 12788 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 5867 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2003 | 2789 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2184 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12786 | 0.010 |
Why?
|
| Myocardium | 1 | 2002 | 4775 | 0.010 |
Why?
|
| Zebrafish | 1 | 2000 | 2995 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 29052 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 23327 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2009 | 40545 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1994 | 2963 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 72252 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12798 | 0.000 |
Why?
|
| Gene Expression | 1 | 1995 | 7793 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18107 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1994 | 4251 | 0.000 |
Why?
|
| Aging | 1 | 1994 | 8655 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1991 | 19232 | 0.000 |
Why?
|
| Rats | 1 | 1991 | 24250 | 0.000 |
Why?
|